Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- BUSINESS NEWS IN BRIEF -2-
June 25, 2001
- BUSINESS NEWS IN BRIEF -1-
June 25, 2001
- Globalization of Japanese Firms Discussed: UBS Warburg Conference
June 25, 2001
- Japanese Global Strategy Update (3)
June 25, 2001
- OTC NEWS IN BRIEF
June 25, 2001
- WORLD NEWS IN BRIEF
June 25, 2001
- Profitability Higher for Medical Equipment Importers Than Manufacturers: Survey
June 25, 2001
- Fukuda Denshi to Boost Sales to \100 Billion in 2010
June 25, 2001
- JMA President Criticizes Ceiling System for Medical Costs
June 25, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
June 25, 2001
- Drug Dispensing Costs Outgrow Bungyo: JMA
June 25, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
June 25, 2001
- REGULATORY NEWS IN BRIEF -2-
June 25, 2001
- Information on Physicians Most Wanted by Citizens: Survey
June 25, 2001
- REGULATORY NEWS IN BRIEF -1-
June 25, 2001
- Korosho Survey Shows Hypertension, Hyperlipidemia Increasing in Men Aged 30 to 50
June 25, 2001
- CEFP Calls For Review of Public Health Insurance Coverage
June 25, 2001
- More Disclosure Needed for Patient-oriented Medical Services: HPB Director General
June 25, 2001
- FPMAJ Proposes Authorized Price Reimbursement Method
June 25, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
June 25, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…